CONMED CORP (CNMD) Stock Fundamental Analysis
NYSE:CNMD • US2074101013
45.14 USD
+0.57 (+1.28%)
At close: Feb 20, 2026
45.14 USD
0 (0%)
After Hours: 2/20/2026, 8:25:21 PM
CNMD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. CNMD has an average financial health and profitability rating. CNMD may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
- CNMD had positive earnings in the past year.
- CNMD had a positive operating cash flow in the past year.
- Of the past 5 years CNMD 4 years were profitable.
- CNMD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- CNMD has a better Return On Assets (2.77%) than 75.68% of its industry peers.
- With a decent Return On Equity value of 6.38%, CNMD is doing good in the industry, outperforming 78.92% of the companies in the same industry.
- CNMD's Return On Invested Capital of 4.94% is fine compared to the rest of the industry. CNMD outperforms 75.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROIC | 4.94% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of CNMD (4.77%) is better than 76.76% of its industry peers.
- CNMD's Profit Margin has improved in the last couple of years.
- CNMD has a better Operating Margin (9.99%) than 78.38% of its industry peers.
- In the last couple of years the Operating Margin of CNMD has grown nicely.
- CNMD has a Gross Margin (54.22%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of CNMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% |
OM growth 3Y15.88%
OM growth 5Y7.91%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y1.06%
GM growth 5Y0.77%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CNMD is destroying value.
- CNMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- CNMD has an Altman-Z score of 1.93. This is not the best score and indicates that CNMD is in the grey zone with still only limited risk for bankruptcy at the moment.
- CNMD has a Altman-Z score of 1.93. This is in the better half of the industry: CNMD outperforms 61.62% of its industry peers.
- CNMD has a debt to FCF ratio of 5.74. This is a neutral value as CNMD would need 5.74 years to pay back of all of its debts.
- The Debt to FCF ratio of CNMD (5.74) is better than 77.84% of its industry peers.
- A Debt/Equity ratio of 0.85 indicates that CNMD is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.85, CNMD is doing worse than 72.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Altman-Z | 1.93 |
ROIC/WACC0.55
WACC9.03%
2.3 Liquidity
- CNMD has a Current Ratio of 2.10. This indicates that CNMD is financially healthy and has no problem in meeting its short term obligations.
- CNMD has a Current ratio (2.10) which is in line with its industry peers.
- CNMD has a Quick Ratio of 2.10. This is a bad value and indicates that CNMD is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.95, CNMD is not doing good in the industry: 78.92% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
- CNMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.82%, which is quite good.
- The Earnings Per Share has been growing by 16.37% on average over the past years. This is quite good.
- Looking at the last year, CNMD shows a small growth in Revenue. The Revenue has grown by 5.18% in the last year.
- The Revenue has been growing by 9.77% on average over the past years. This is quite good.
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%
3.2 Future
- CNMD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.09% yearly.
- The Revenue is expected to grow by 3.55% on average over the next years.
EPS Next Y-1.76%
EPS Next 2Y4.92%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue Next Year0.29%
Revenue Next 2Y2.72%
Revenue Next 3Y3.55%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 9.79, the valuation of CNMD can be described as reasonable.
- CNMD's Price/Earnings ratio is rather cheap when compared to the industry. CNMD is cheaper than 95.14% of the companies in the same industry.
- CNMD is valuated cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 9.97, the valuation of CNMD can be described as very reasonable.
- CNMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. CNMD is cheaper than 95.14% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, CNMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.79 | ||
| Fwd PE | 9.97 |
4.2 Price Multiples
- 90.81% of the companies in the same industry are more expensive than CNMD, based on the Enterprise Value to EBITDA ratio.
- CNMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CNMD is cheaper than 98.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.4 | ||
| EV/EBITDA | 10.51 |
4.3 Compensation for Growth
- The decent profitability rating of CNMD may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.6
EPS Next 2Y4.92%
EPS Next 3Y7.09%
5. Dividend
5.1 Amount
- CNMD has a Yearly Dividend Yield of 1.92%.
- CNMD's Dividend Yield is rather good when compared to the industry average which is at 0.20. CNMD pays more dividend than 95.68% of the companies in the same industry.
- CNMD's Dividend Yield is comparable with the S&P500 average which is at 1.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.92% |
5.2 History
- The dividend of CNMD decreases each year by -0.01%.
- CNMD has been paying a dividend for at least 10 years, so it has a reliable track record.
- CNMD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
- 39.73% of the earnings are spent on dividend by CNMD. This is a low number and sustainable payout ratio.
DP39.73%
EPS Next 2Y4.92%
EPS Next 3Y7.09%
45.14
+0.57 (+1.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-28 2026-01-28/amc
Earnings (Next)04-28 2026-04-28/amc
Inst Owners114.3%
Inst Owner Change-2.77%
Ins Owners0.29%
Ins Owner Change0.45%
Market Cap1.40B
Revenue(TTM)1.37B
Net Income(TTM)64.32M
Analysts73.33
Price Target49.57 (9.81%)
Short Float %7.38%
Short Ratio3.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.92% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP39.73%
Div Incr Years0
Div Non Decr Years12
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.52%
Min EPS beat(2)0.37%
Max EPS beat(2)0.66%
EPS beat(4)4
Avg EPS beat(4)6.26%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.08%
EPS beat(12)10
Avg EPS beat(12)-0.4%
EPS beat(16)13
Avg EPS beat(16)0.52%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-1.03%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.61%
PT rev (1m)0.41%
PT rev (3m)-21.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.27%
EPS NY rev (3m)-6.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)-4.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.79 | ||
| Fwd PE | 9.97 | ||
| P/S | 1.04 | ||
| P/FCF | 9.4 | ||
| P/OCF | 8.35 | ||
| P/B | 1.39 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.51 |
EPS(TTM)4.61
EY10.21%
EPS(NY)4.53
Fwd EY10.03%
FCF(TTM)4.8
FCFY10.64%
OCF(TTM)5.4
OCFY11.97%
SpS43.51
BVpS32.56
TBVpS-12.65
PEG (NY)N/A
PEG (5Y)0.6
Graham Number58.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROCE | 6.7% | ||
| ROIC | 4.94% | ||
| ROICexc | 5.04% | ||
| ROICexgc | 17.43% | ||
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% | ||
| FCFM | 11.04% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y15.88%
OM growth 5Y7.91%
PM growth 3YN/A
PM growth 5Y25.45%
GM growth 3Y1.06%
GM growth 5Y0.77%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Debt/EBITDA | 4.09 | ||
| Cap/Depr | 25.13% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.15% | ||
| Profit Quality | 231.2% | ||
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.93 |
F-Score5
WACC9.03%
ROIC/WACC0.55
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.82%
EPS 3Y20.27%
EPS 5Y16.37%
EPS Q2Q%6.72%
EPS Next Y-1.76%
EPS Next 2Y4.92%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y9.55%
Revenue growth 5Y9.77%
Sales Q2Q%7.88%
Revenue Next Year0.29%
Revenue Next 2Y2.72%
Revenue Next 3Y3.55%
Revenue Next 5YN/A
EBIT growth 1Y-35.26%
EBIT growth 3Y26.95%
EBIT growth 5Y18.45%
EBIT Next Year29.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.2%
OCF growth 3YN/A
OCF growth 5YN/A
CONMED CORP / CNMD FAQ
What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CNMD.
Can you provide the valuation status for CONMED CORP?
ChartMill assigns a valuation rating of 7 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.
How profitable is CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for CNMD stock?
The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 9.79 and the Price/Book (PB) ratio is 1.39.
What is the expected EPS growth for CONMED CORP (CNMD) stock?
The Earnings per Share (EPS) of CONMED CORP (CNMD) is expected to decline by -1.76% in the next year.